Market revenue in 2023 | USD 195.3 million |
Market revenue in 2030 | USD 306.2 million |
Growth rate | 6.6% (CAGR from 2023 to 2030) |
Largest segment | Peripheral stents |
Fastest growing segment | Endovascular Aneurysm Repair Stent Grafts |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | PTA Balloons, Catheters, Endovascular Aneurysm Repair Stent Grafts, Plaque Modification Devices, Peripheral Accessories, Inferior Vena Cava Filters, Hemodynamic Flow Alteration Devices, Peripheral Stents |
Key market players worldwide | Abbott Laboratories, Edwards Lifesciences Corp, Medtronic PLC, St. Jude Medical, Teleflex Inc, Philips, Boston Scientific Corp, Cook Group, Covidien, AngioScore |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to peripheral vascular devices market will help companies and investors design strategic landscapes.
Peripheral stents was the largest segment with a revenue share of 28.57% in 2024. Horizon Databook has segmented the Australia peripheral vascular devices market based on pta balloons, catheters, endovascular aneurysm repair stent grafts, plaque modification devices, peripheral accessories, inferior vena cava filters, hemodynamic flow alteration devices, peripheral stents covering the revenue growth of each sub-segment from 2018 to 2030.
The peripheral vascular devices market in Australia is expected to witness a dynamic and competitive landscape, marked by active participation from various regional entities striving for dominance. Some of the key players in the market include Medtronic, Boston Scientific, Abbott Laboratories, and Cordis Corporation, among others.
Growth in the market can be attributed to the rising prevalence of PAD, increasing adoption of minimally invasive procedures, and rising healthcare expenditure. Moreover, technological advancements in peripheral vascular devices and the growing elderly population are some of the major factors expected to propel market growth.
As per the reports published and the latest updated in October 2023 by the Australian Institute of Health and Welfare-Health expenditure Australia, total health expenditure amounted to USD 241.3 billion, equivalent to USD 9,365 per person.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia peripheral vascular devices market, including forecasts for subscribers. This country databook contains high-level insights into Australia peripheral vascular devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account